Comorbidities and Cardiovascular Risk Factors in Older Adults Undergoing Anticancer Therapy
In the dynamic landscape of healthcare, the broadcast 'Comorbidities and Cardiovascular Risk Factors in Older Adults Undergoing Anticancer Therapy' serves as an essential resource for healthcare professionals. The expert faculty will delve into the intricate relationship between comorbidities, cardiovascular risk factors, and anticancer therapies, with a specific focus on older adults. This event provides healthcare practitioners with valuable insights to address the unique challenges of caring for this vulnerable patient group. By enhancing clinical decision-making and patient care pathways, it empowers professionals to deliver comprehensive, patient-centered care to older adults facing the dual challenges of cancer and cardiovascular conditions.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
The Multinational Association of Supportive Care in Cancer (MASCC) is an international, interdisciplinary organisation dedicated to the practice, education and research of supportive care in cancer. MASCC mission is to continually improve the supportive care of people with cancer – from diagnosis through to survival or end-of-life care.
This is an independent activity run by the International Cardio-Oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. The IC-OS has been provided support to deliver this webinar series by AstraZeneca, BMS/Pfizer Alliance, Eli Lilly and Roche through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
Ishwaria M Subbiah
This broadcast is supported by
Prof Daniel Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Prof Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US the Chief Operating Officer of the Abramson Family Cancer Research Institute and the Chief of Staff of the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.
Ishwaria M Subbiah
Dr Ishwaria Subbiah, is a medical oncologist and palliative care physician and serves as the Executive Director, Cancer Care Equity and Professional Wellness at the Sarah Cannon Research Institute as well as the Medical Director, Supportive Care Oncology, Health Equity, and Professional Well-being for The US Oncology Network. In these complementary roles, Dr Subbiah leads the network-wide oncology professional well-being strategy and partners with key teams to enhance symptom management services including palliative care, evidence-based cancer care for older adults, advanced practice provider education, and equity initiatives that broaden clinical trials access across the integrated national cancer care network that cares for 1.4 million people with cancer every year across 250 clinical practices in 24 states with 1,300 oncology physicians.
Dr Avirup Guha, Assistant Professor at Augusta University, leads Cardio-Oncology at the Medical College of Georgia, Augusta, US. Dr Guha's ongoing research, under the patronage of the American Heart Association and the Department of Defense, delves deep into the translational science concerning biological disparities between White and Black men with prostate cancer (PC) undergoing androgen deprivation therapy (ADT). A key focal point is the exploration of the Nicotinamide Adenine Dinucleotide pathway and its influence on vascular aging, further probing how social determinants of health modify its effects in the mentioned demographic. He is board-certified in cardiology, cardio-oncology, echocardiography, and several other cardiac imaging modalities.